Both p16 <sup>Ink4a</sup> and the p19 <sup>Arf</sup> -p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse

Bardeesy, Nabeel; J. Aguirre, Andrew; C. Chu, Gerald; Cheng, Kuang‐Hung; V. Lopez, Lyle; F. Hezel, Aram; Feng, Bin; Brennan, Cameron; Weissleder, Ralph; Mahmood, Umar; Hanahan, Douglas; Redston, Mark; Chin, Lynda; A. DePinho, Ronald

doi:10.1073/pnas.0601273103

Public

Both p16 Ink4a and the p19 Arf -p53 pathway constrain progression of pancreatic adenocarcinoma in the mouse

Published in Proceedings of the National Academy of Sciences • Apr 3, 2006

Authors:

Nabeel Bardeesy

Andrew J. Aguirre

Gerald C. Chu

Abstract

Activating KRAS mutations and p16(Ink4a) inactivation are near universal events in human pancreatic ductal adenocarcinoma (PDAC). In mouse models, Kras(G12D) initiates formation of premalignant pancreatic ductal lesions, and loss of either Ink4a/Arf (p16(Ink4a)/p19(Arf)) or p53 enables their maligna...

Subject

Cancer research

KRAS

Biology

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!